Last Updated: August 30, 2011
Clifford Kamara, MD, MPH

Source:
1. WHO Vaccine Preventable Disease Monitoring System, 2008. Immunization Profile: Nigeria. All data derived from the WHO/UNICEF Joint Reporting Form as follows:
a: C_6450. This % excludes any external financing from donors.
b: C_6490. This % includes all recurrent, immunization-specific spending financed solely with government funds. This includes vaccines, injection supplies, salaries, and per diems of health staff working full-time on immunization, transport, vehicles, and cold chain maintenance, training, social mobilization, and monitoring and surveillance.
"NA" indicates data not available.

(Source: Nigeria Health System Assessment 2008, USAID/ Abt. Associates)
Percent of districts reporting at least 80% coverage (DPT3), 2008*: 32%

*Source:
WHO Vaccine Preventable Disease Monitoring System, 2008. Immunization Profile: Nigeria. Data derived from the WHO/UNICEF Joint Reporting Form, Indicator GSA17ap. "NA" indicates data not available.
Population (2008): 151,212,000
Births (2008): 6,028,000
U5 Deaths (2008):
- total 1,077,000
- preventable by routine EPI: 150,7801
- preventable by routine EPI and new vaccines: 269,2502
(Source: UNICEF "State of the World's Children" 2009 )
1 Assumes use of BCG, DPT, polio, and measles vaccines prevent 14% of U5 deaths.
2 Assumes use of BCG, DPT, polio, measles, HepB, Hib, yellow fever, and pneumococcal antigen-containing vaccines prevent 25% of U5 deaths.
Note: Vaccine preventable death estimates assume that force of infections, individual susceptibility, and probability of exposure are constant at all mortality levels.